Context Therapeutics Inc. - Common Stock, par value $0.001 per share (CNTX)

Historical Holders from Q4 2021 to Q3 2025

Symbol
CNTX on Nasdaq
Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
92,935,152
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
68,966,266
Holdings value
$66,815,968
% of all portfolios
0%
Number of holders
37
Number of buys
12
Number of sells
-14
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Context Therapeutics Inc. - Common Stock, par value $0.001 per share (CNTX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
MPM BioImpact LLC 16.4% $14,705,882 14,705,882 MPM BioImpact LLC 31 Dec 2024
Avidity Partners Management LP 9.9% 0% $8,913,522 +$72,083 9,200,580 +0.82% Avidity Partners Management LP 30 Sep 2025
Deep Track Capital, LP 8.27% $7,419,355 7,419,355 Deep Track Capital, LP 31 Mar 2025
Blue Owl Capital Holdings LP 8.48% $6,357,928 6,357,928 Blue Owl Capital Holdings LP 31 Dec 2024
GREAT POINT PARTNERS LLC 5.22% 0% $4,537,579 4,683,711 0% Great Point Partners, LLC 30 Sep 2025
FRANKLIN RESOURCES INC 4.5% -16% $4,003,380 4,003,380 0% Franklin Resources, Inc. 31 Mar 2025
Lehr Martin A. 2.1% $1,595,742 1,595,742 Martin Lehr 31 Dec 2024

Institutional Holders of Context Therapeutics Inc. - Common Stock, par value $0.001 per share (CNTX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 68,966,266 $66,815,968 +$689,909 $0.9688 37
2025 Q2 68,619,580 $44,959,003 -$1,721,044 $0.6552 39
2025 Q1 71,405,968 $43,712,940 -$1,099,517 $0.612 42
2024 Q4 72,797,034 $76,436,064 +$15,827,475 $1.05 52
2024 Q3 56,682,696 $111,154,599 -$854,175 $1.96 42
2024 Q2 57,034,586 $114,325,460 +$107,182,399 $2 34
2024 Q1 3,935,132 $5,430,813 +$524,452 $1.38 25
2023 Q4 3,558,639 $4,020,714 +$1,102,318 $1.13 24
2023 Q3 2,578,656 $3,893,359 +$507,040 $1.51 23
2023 Q2 2,239,166 $3,582,021 +$1,631,639 $1.6 22
2023 Q1 1,276,355 $717,889 -$1,585,759 $0.5622 20
2022 Q4 3,883,345 $2,545,096 -$383,818 $0.6517 23
2022 Q3 4,130,839 $4,587,000 +$1,461,710 $1.11 21
2022 Q2 2,747,803 $5,761,000 -$388,653 $2.12 17
2022 Q1 2,904,420 $6,302,000 -$2,229,327 $2.17 12
2021 Q4 3,549,370 $9,441,000 +$8,486,000 $2.66 16